explore -WSS

explore

author：entertainment 2025-10-03 00:07:56 - browse：82855

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

LEXINGTON, Mass. — New obesity drugs like Wegovy and Zepbound are currently taken once a week, indefinitely. But what if they could be taken once a year instead, like a vaccine?

That’s a question that Novo Nordisk, the pharma company behind Wegovy, is exploring as it faces increased competition from other drugmakers aiming to develop similar GLP-1-based treatments for obesity.

“We have a very early think tank on: what would it take us, from a technology point of view and from an ecosystem point of view, to make long-lasting GLP-1 molecules?” Marcus Schindler, Novo’s chief scientific officer, said in an interview with STAT Wednesday. “Could we think about vaccine-like properties, where imagine you had, once a year, an injection with an equivalent of a GLP-1 that really helps you to maintain weight loss and have cardiovascular benefits?”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： Bring on the sabbaticals for nurses

WSS

Ibogaine psychedelic therapy for opioid addiction unlikely, official says

Eli Lilly’s Zepbound improved liver scarring in mid

Bring on the sabbaticals for nurses

U.K. officials, researchers try to ease path for bespoke genetic treatments

STAT wants to know your pick for a great summer read or listen

FDA approves Moderna’s RSV vaccine, its second licensed product

explore

explore

knowledge

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

The most pressing bird flu mysteries scientists want answered

At least 13 dead in Texas as scorching temps continue

Adam's Take: Intra

New air purifier tech could be key to improving indoor air quality

What Kate Middleton's cancer revelation might teach the world

What does generative AI mean for health care? We asked experts

Data don't support strong claims for Covid

What does generative AI mean for health care? We asked experts

CRISPR technology availability, affordability needs to be expanded

hotspot

Testing GLP

Senators tussle over abortion against the backdrop of a presidential campaign

Medicare Advantage insurers pressure Biden for bigger payments

Stopping antidepressants leads to symptoms for 1 in 6 patients

Erich Jarvis studies song birds to learn about human stuttering

UnitedHealth CEO's Medicaid comments send insurer stocks diving

hotspot

explore

entertainment

leisure time